Evelo Biosciences Inc (EVLO)
US Market

Evelo Biosciences (EVLO) Stock Price & Analysis


EVLO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.48 - $48.40
Previous Close$4.11
Average Volume (3M)603.36K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$7.62M
Total Debt (Recent Filing)$50.48M
Price to Earnings (P/E)-0.2
Nov 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.30
Shares Outstanding18,835,066
10 Day Avg. Volume113,708
30 Day Avg. Volume603,355
Standard Deviation0.42
Financial Highlights & Ratios
Price to Book (P/B)-1.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside139.81% Upside
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Evelo Biosciences Inc’s price range in the past 12 months?
Evelo Biosciences Inc lowest stock price was $0.48 and its highest was $48.40 in the past 12 months.
    What is Evelo Biosciences Inc’s market cap?
    Currently, no data Available
    When is Evelo Biosciences Inc’s upcoming earnings report date?
    Evelo Biosciences Inc’s upcoming earnings report date is Nov 02, 2023 which is in 35 days.
      How were Evelo Biosciences Inc’s earnings last quarter?
      Evelo Biosciences Inc released its earnings results on Aug 14, 2023. The company reported -$3.78 earnings per share for the quarter, missing the consensus estimate of -$3.263 by -$0.517.
        Is Evelo Biosciences Inc overvalued?
        According to Wall Street analysts Evelo Biosciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Evelo Biosciences Inc pay dividends?
          Evelo Biosciences Inc does not currently pay dividends.
          What is Evelo Biosciences Inc’s EPS estimate?
          Evelo Biosciences Inc’s EPS estimate is -$0.91.
            How many shares outstanding does Evelo Biosciences Inc have?
            Evelo Biosciences Inc has 18,835,066 shares outstanding.
              What happened to Evelo Biosciences Inc’s price movement after its last earnings report?
              Evelo Biosciences Inc reported an EPS of -$3.78 in its last earnings report, missing expectations of -$3.263. Following the earnings report the stock price went up 28.628%.
                Which hedge fund is a major shareholder of Evelo Biosciences Inc?
                Among the largest hedge funds holding Evelo Biosciences Inc’s share is Flagship Pioneering Inc.. It holds Evelo Biosciences Inc’s shares valued at 8M.


                  Evelo Biosciences Stock Smart Score

                  The Evelo Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Evelo Biosciences Inc

                  Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding EVLO

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold EVLO. The ETFs are listed according to market value of EVLO within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aclaris Therapeutics
                  Aileron Therapeutics
                  Arvinas Holding Company
                  Bioxcel Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis